Frontier Biotech

Last updated: 07.11.2019


Company info
Founded in 2013, Frontier Biotechnologies Inc. (“Frontier Biotech”) is a commercial-stage biopharmaceutical company headquartered in China with global vision and world-class competitiveness. Frontier Biotech is committed to discovering, development, manufacturing, and commercialization of innovative medicines that improve patient health. Our medicines typically address the unmet medical needs of patients in the areas of anti-HIV treatment and pain management.

Frontier Biotech’s first commercial product was approved by the National Medical Product Administration (NMPA), which is the counterpart of the Food and Drug Administration (FDA) in China, in May 2018 through a priority review process and has gained accelerated approval. Two additional drug candidates are currently undergoing multiple clinical trials in Phase I and Phase II in both China and the United States.


Address: 6th Floor, Building C3, Greenland, Yupan West Street, Yuhuatai District, Nanjing, China





We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here